Close Menu

Nobel laureate Elizabeth Blackburn has launched a company called Telome Health, and has created a commercial genetic test to measure telomere shortening, to give people insight on their aging process, reports Boonsri Dickinson at New Scientist. Blackburn says telomere length can give a patient a "sense of your underlying health," as researchers see telomere shortening in conditions like heart disease and cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.